Differences in the behavior of advanced glycation end products and advanced oxidation protein products in patients with allergic rhinitis.

BACKGROUND The presence of oxidative stress in patients with asthma is well documented; however, the role of oxidative stress in allergic rhinitis has received less attention, although it is likely to be similar to that observed in patients with asthma. Advanced glycation end products (AGEs) and advanced oxidation protein products (AOPPs) are compounds formed by the transformation of macromolecules, including proteins, which can serve as densitometric markers of oxidative stress and inflammation in several diseases. OBJECTIVE The aim of this study was to investigate the role of AGEs and AOPPs as new markers of oxidative stress and inflammation in patients affected by allergic rhinitis. METHODS AGE and AOPP levels were determined in the sera of 25 patients with allergic rhinitis and 64 healthy controls. AGEs and AOPPs were detected using spectrofluorimetry and spectrophotometry, respectively. RESULTS AGE levels in patients were significantly higher than those in controls (P < .0001). These levels were not affected by the presence of asthma. No statistically significant differences were found between AOPP levels in patients or controls (P = .38). CONCLUSIONS Formation of AGEs and AOPPs may be accelerated in immunological and respiratory disorders such as asthma. Depending on the marker evaluated, the presence or absence of oxidative stress in allergic rhinitis is controversial. To our knowledge, this is the first study showing the possible involvement of AGEs in allergic rhinitis. The different behavior observed for these 2 biomarkers is very likely due to the activation of specific related biochemical pathways (eg, the myeloperoxidase pathway) associated with the condition under study.

[1]  O. Kalayci,et al.  Oxidative stress in the airways of children with asthma and allergic rhinitis , 2012, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[2]  S. Gangemi,et al.  Increased serum levels of advanced oxidation protein products and glycation end products in subjects exposed to low-dose benzene. , 2012, International journal of hygiene and environmental health.

[3]  A. Allegra,et al.  Relationship Between Advanced Oxidation Protein Products, Advanced Glycation End Products, and S-Nitrosylated Proteins With Biological Risk and MDR-1 Polymorphisms in Patients Affected by B-Chronic Lymphocytic Leukemia , 2012, Cancer investigation.

[4]  A. Smit,et al.  Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease , 2011, Arthritis research & therapy.

[5]  R. Oçal,et al.  Oxidative stress status and plasma trace elements in patients with asthma or allergic rhinitis. , 2011, Allergologia et immunopathologia.

[6]  K. Hirata,et al.  Potential roles of pentosidine in age-related and disease-related impairment of pulmonary functions in patients with asthma. , 2011, The Journal of allergy and clinical immunology.

[7]  P. Black,et al.  Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD. , 2011, Respiratory medicine.

[8]  K. Carlsen,et al.  Altered oxidative state in schoolchildren with asthma and allergic rhinitis , 2011, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[9]  N. Martinelli,et al.  Differences and Similarities between Allergic and Nonallergic Rhinitis in a Large Sample of Adult Patients with Rhinitis Symptoms , 2011, International Archives of Allergy and Immunology.

[10]  Xiao-lan Li,et al.  Antioxidant Status and Immune Activity of Glycyrrhizin in Allergic Rhinitis Mice , 2011, International journal of molecular sciences.

[11]  F. Munschauer,et al.  AGE-RAGE in Multiple Sclerosis Brain , 2011, Immunological investigations.

[12]  Edyta Bieszczad-Bedrejczuk,et al.  Protective effect of desloratadine against oxidative stress in human erythrocytes in vitro. , 2010, Environmental toxicology and pharmacology.

[13]  Hong Wang,et al.  [Changes of oxidative stress in peripheral serum of patients with allergic rhinitis]. , 2010, Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery.

[14]  A. Fitzpatrick,et al.  Obesity, asthma, and oxidative stress. , 2010, Journal of applied physiology.

[15]  A. Piwowar.  [Advanced oxidation protein products. Part I. Mechanism of the formation, characteristics and property]. , 2010, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.

[16]  F. Aksoy,et al.  Advanced oxidation protein products as an oxidative stress marker in allergic rhinitis. , 2009, Kulak burun bogaz ihtisas dergisi : KBB = Journal of ear, nose, and throat.

[17]  H. Scharnagl,et al.  Plasma-Advanced Oxidation Protein Products Are Potent High-Density Lipoprotein Receptor Antagonists In Vivo , 2009, Circulation research.

[18]  K. Kostikas,et al.  Inflammatory and oxidative stress biomarkers in allergic rhinitis: the effect of smoking , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[19]  C. Roussos,et al.  Breath Markers of Oxidative Stress and Airway Inflammation in Seasonal Allergic Rhinitis , 2008, International journal of immunopathology and pharmacology.

[20]  G. Viegi,et al.  Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 * , 2008, Allergy.

[21]  K. Hirata,et al.  Nε-(Carboxymethyl)Lysine, a Major Advanced Glycation End Product in Exhaled Breath Condensate as a Biomarker of Small Airway Involvement in Asthma , 2007, The Journal of asthma : official journal of the Association for the Care of Asthma.

[22]  V. Sathiyapriya,et al.  Evidence for the role of lipid peroxides on glycation of hemoglobin and plasma proteins in non-diabetic asthma patients. , 2006, Clinica chimica acta; international journal of clinical chemistry.

[23]  V. Tesar,et al.  Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background. , 2005, Mutation research.

[24]  S. Fustinoni,et al.  [Biologically effective dose biomarkers]. , 2004, Giornale italiano di medicina del lavoro ed ergonomia.

[25]  G. Folkerts,et al.  Asthma and Oxidative Stress , 2004 .

[26]  N. Martinelli,et al.  Randomized placebo‐controlled trial comparing fluticasone aqueous nasal spray in mono‐therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[27]  H. Tsukahara,et al.  High levels of urinary pentosidine, an advanced glycation end product, in children with acute exacerbation of atopic dermatitis: relationship with oxidative stress. , 2003, Metabolism: clinical and experimental.

[28]  J. Heinecke,et al.  Production of N(epsilon)-(carboxymethyl)lysine is impaired in mice deficient in NADPH oxidase: a role for phagocyte-derived oxidants in the formation of advanced glycation end products during inflammation. , 2003, Diabetes.

[29]  R. Bowler,et al.  Oxidative stress in allergic respiratory diseases. , 2002, The Journal of allergy and clinical immunology.

[30]  W. Stahel,et al.  Air pollutants enhance rhinoconjunctivitis symptoms in pollen-allergic individuals. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[31]  T. Kobayashi,et al.  Exposure to ozone aggravates nasal allergy-like symptoms in guinea pigs. , 2001, Toxicology letters.

[32]  J. Crowley,et al.  The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation. , 1999, The Journal of clinical investigation.

[33]  C. Caruso,et al.  Allergic rhinitis to grass pollen: measurement of inflammatory mediators of mast cell and eosinophils in native nasal fluid lavage and in serum out of and during pollen season. , 1997, The Journal of allergy and clinical immunology.

[34]  A. Hasan,et al.  Total antioxidant status and oxidative stress and their relationship to total IgE levels and eosinophil counts in children with allergic rhinitis. , 2012, Journal of investigational allergology & clinical immunology.

[35]  Y. Uyar,et al.  [Oxidative stress and antioxidant factors in pathophysiology of allergic rhinitis]. , 2007, Kulak burun bogaz ihtisas dergisi : KBB = Journal of ear, nose, and throat.

[36]  A. Długosz,et al.  [Markers of oxidative balance and concentration of selected metals in pollinotics]. , 2005, Przeglad lekarski.

[37]  N. Martinelli,et al.  Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in monotherapy , fluticasone plus cetirizine , fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis , 2004 .

[38]  U. Markert,et al.  Elevated nonspecific plasma proteins in allergic patients. , 2003, Journal of investigational allergology & clinical immunology.

[39]  T. Kumoi,et al.  Hydrogen peroxide generation by eosinophils in allergic rhinitis. , 1991, Auris, nasus, larynx.